Statins: Clinical Trials

7 trials for Statins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 active not recruiting, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 21Unknown 1
Phase 31Unknown 1
Phase 41Active not recruiting 1

Follow Statins: new trials by email Literature Review of Statins trials Research Report on Statins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statins, Cholesterol and Cognitive Decline in Alzheimer's
STA 4783 - Alzheimer Dementia, Statins
CompletedKarolinska Institutet20002025-01-012025-05-02
Interactions of Medicine and Exercise With Meal Timing
EXERCISE TRAINING WITH OR WITHOUT MEDICATION - Metabolic Syndrome, Protection Against, Exercise Training
Not applicableUnknownUniversity of Castilla-La Mancha1602022-06-072023-08-25
Study of Adherence to Antihypertensive Drugs and Statins by Hair Analysis
Hair analysis for drug concentration - Arterial Hypertension, Dyslipidemias
UnknownAzienda Ospedaliera Universitaria Integrata Verona2002022-05-152022-05-02
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
Pitavastatin, PCSK9 inhibitor - Dyslipidemias, Hyperlipidemias
Phase 4Active not recruitingNational Medical Research Center for Therapy and Preventive Medicine592021-10-012025-01-22
Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
Statin - Intracerebral Hemorrhage, Statins
Phase 2 / Phase 3UnknownCapital Medical University982021-08-062024-01-23
Statin Eligibility Prior to Myocardial InfarCtion
No intervention - Statins, Myocardial Infarction
TerminatedJordan Collaborating Cardiology Group7402019-04-222019-06-26
Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Healthy Volunteers, Statins
CompletedNational Heart, Lung, and Blood Institute (NHLBI)202010-07-012018-10-09

Narrower conditions

Dyslipidemias (3)  ·  Hypertension (2)  ·  Alzheimer Disease (1)  ·  Cerebral Hemorrhage (1)  ·  Hyperlipidemias (1)  ·  Insulin Resistance (1)  ·  Intermittent Fasting (1)  ·  Metabolic Syndrome (1)  ·  Myocardial Infarction (1)  ·  Treatment Adherence and Compliance (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Lipid Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Behavior (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Cerebrovascular Disorders (1)  ·  Dementia (1)  ·  Fasting (1)  ·  Feeding Behavior (1)

Interventions

Hydroxymethylglutaryl-CoA Reductase Inhibitors (2)  ·  Blood Pressure Monitoring, Ambulatory (1)  ·  Blood Specimen Collection (1)  ·  Dosage Forms (1)  ·  Exercise (1)  ·  Hair Analysis (1)  ·  Metformin (1)  ·  elesclomol (1)  ·  pitavastatin (1)

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Capital Medical University (1)  ·  Jordan Collaborating Cardiology Group (1)  ·  Karolinska Institutet (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Medical Research Center for Therapy and Preventive Medicine (1)  ·  University of Castilla-La Mancha (1)

Countries

China (1)  ·  Italy (1)  ·  Jordan (1)  ·  Russia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Alexandra Ershova, PhD (1)  ·  Angelique Biancotto, Ph.D. (1)  ·  Ayman J Hammoudeh, MD, FACC (1)  ·  Franco Tagliaro, MD (1)  ·  Yasmine Obeidat, MS (1)

Results publications

PMID 12076376, PMID 16790458, PMID 22024657, PMID 22748400, PMID 24990547, PMID 27191185, PMID 27866243, PMID 29249596, PMID 29981458, PMID 30165516, PMID 30920930, PMID 31163981, PMID 31573980, PMID 32219670, PMID 33186492, PMID 38015017, PMID 38908848